东吴证券给予南微医学买入评级：主业稳健发展，出海布局领先

Core Viewpoint - Dongwu Securities issued a report on August 11, giving Nanwei Medical (688029.SH, latest price: 92.39 yuan) a "buy" rating based on its increasing overseas revenue proportion and strong international performance [2] Group 1 - The overseas revenue proportion of Nanwei Medical continues to rise [2] - The company is making solid progress in internationalization, with impressive overseas performance [2]